A detailed history of North Rock Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, North Rock Partners, LLC holds 4,353 shares of LLY stock, worth $3.47 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
4,353
Previous 5,399 19.37%
Holding current value
$3.47 Million
Previous $4.89 Million 21.11%
% of portfolio
0.34%
Previous 0.42%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$772.14 - $960.02 $807,658 - $1 Million
-1,046 Reduced 19.37%
4,353 $3.86 Million
Q2 2024

Aug 06, 2024

SELL
$724.87 - $909.04 $381,281 - $478,155
-526 Reduced 8.88%
5,399 $4.89 Million
Q1 2024

May 07, 2024

BUY
$592.2 - $792.28 $340,515 - $455,561
575 Added 10.75%
5,925 $4.61 Million
Q4 2023

Feb 08, 2024

BUY
$525.19 - $619.13 $92,433 - $108,966
176 Added 3.4%
5,350 $3.12 Million
Q3 2023

Oct 24, 2023

BUY
$434.7 - $599.3 $486,429 - $670,616
1,119 Added 27.6%
5,174 $2.78 Million
Q2 2023

Aug 02, 2023

SELL
$350.74 - $468.98 $119,602 - $159,922
-341 Reduced 7.76%
4,055 $1.9 Million
Q1 2023

May 03, 2023

SELL
$310.63 - $364.82 $244,155 - $286,748
-786 Reduced 15.17%
4,396 $1.51 Million
Q4 2022

Feb 01, 2023

BUY
$321.55 - $374.67 $335,376 - $390,780
1,043 Added 25.2%
5,182 $1.9 Million
Q3 2022

Nov 02, 2022

BUY
$296.48 - $337.87 $64,336 - $73,317
217 Added 5.53%
4,139 $1.34 Million
Q2 2022

Aug 04, 2022

BUY
$278.73 - $327.27 $74,142 - $87,053
266 Added 7.28%
3,922 $1.27 Million
Q1 2022

May 05, 2022

SELL
$234.69 - $291.66 $67,356 - $83,706
-287 Reduced 7.28%
3,656 $1.05 Million
Q4 2021

Feb 07, 2022

BUY
$224.85 - $279.04 $262,175 - $325,360
1,166 Added 41.99%
3,943 $1.09 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $116,118 - $142,900
524 Added 23.26%
2,777 $642,000
Q2 2021

Aug 12, 2021

BUY
$180.55 - $233.54 $121,690 - $157,405
674 Added 42.69%
2,253 $517,000
Q1 2021

May 11, 2021

BUY
$164.32 - $212.72 $16,267 - $21,059
99 Added 6.69%
1,579 $295,000
Q4 2020

Feb 08, 2021

SELL
$130.46 - $172.63 $38,224 - $50,580
-293 Reduced 16.53%
1,480 $250,000
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $28,512 - $32,980
195 Added 12.36%
1,773 $262,000
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $136 - $164
-1 Reduced 0.06%
1,578 $259,000
Q2 2020

Aug 11, 2020

SELL
$136.42 - $164.18 $57,842 - $69,612
-424 Reduced 21.17%
1,579 $259,000
Q1 2020

May 13, 2020

SELL
$119.05 - $147.35 $322,268 - $398,876
-2,707 Reduced 57.47%
2,003 $278,000
Q4 2019

Feb 12, 2020

SELL
$106.92 - $132.43 $636,067 - $787,826
-5,949 Reduced 55.81%
4,710 $619,000
Q4 2019

Feb 12, 2020

BUY
$106.92 - $132.43 $1.14 Million - $1.41 Million
10,659 New
10,659 $619,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $757B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track North Rock Partners, LLC Portfolio

Follow North Rock Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Rock Partners, LLC with notifications on news.